Почетна › Аутоимуне болести › Kalifornija
Kliničke studije za Аутоимуне болести u državi Kalifornija
28 studija za Аутоимуне болести traži učesnike na lokacijama u državi Kalifornija.
Gradovi u državi Kalifornija
- Los Angeles12 студија
- San Francisco7 студија
- Orange7 студија
- Mountain View5 студија
- Sacramento5 студија
- San Diego5 студија
- Irvine3 студија
Zvanični tekst studije (na engleskom)
Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
- Site Number - 1028, Irvine
- Site Number - 1023, Los Angeles
- Site Number - 1029, Rancho Mirage
- и још 1
Тражи се учесникФаза 3
Узраст од 18 до 80 · Оба пола · Ажурирано 13. 11. 2026. · NCT07039916RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
- University of California Irvine - Accepting Adult Patients, Orange
- University of California, San Francisco Benioff Children's Hospital - Accepting Young Adult and Juvenile Patients, San Francisco
Тражи се учесникФаза 2/3
Узраст од 6 до 75 · Оба пола · Ажурирано 13. 11. 2026. · NCT06154252Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- University of California Davis Comprehensive Cancer Center, Sacramento
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT03816345A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections
- UC Irvine, Irvine
- Orso Health, La Jolla
- University of California, Los Angeles-UCLA, Los Angeles
Тражи се учесникФаза 3
Узраст 12 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT06056297Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden
- Medvin Clinical Research, Van Nuys
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 9. 11. 2026. · NCT07621809Study of PTC844 in Participants With Active Rheumatoid Arthritis
- Millennium Clinical Trials, Westlake Village
Тражи се учесникФаза 2
Узраст од 18 до 70 · Оба пола · Ажурирано 6. 11. 2026. · NCT07779616A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- USC Norris Comprehensive Cancer Center - Keck Medicine of USC, Los Angeles
- University of California San Diego Center for Bleeding and Clotting Disorders, San Diego
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT06722235A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
- Loma Linda University Medical Center, Loma Linda
Тражи се учесникФаза 1
Узраст од 18 до 74 · Оба пола · Ажурирано 2. 11. 2026. · NCT07085104A Study of JADE101 in Participants With Immunoglobulin A Nephropathy
- Jade Clinical Site, Chula Vista
Тражи се учесникФаза 2
Узраст од 18 до 60 · Оба пола · Ажурирано 30. 10. 2026. · NCT07541287A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- USC Norris Comprehensive Cancer Center - Keck Medicine of USC, Los Angeles
- University of California San Diego Center for Bleeding and Clotting Disorders, San Diego
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 30. 10. 2026. · NCT06948318Study of Anitocabtagene Autoleucel in Participants With Non-Oncology Plasma Cell-Related Diseases
- Ronald Reagan UCLA Medical Center, Los Angeles
- UC Irvine Medical Center, Orange
- Stanford Blood and Marrow Transplant, Palo Alto
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 22. 10. 2026. · NCT06626919A Study Investigating Intravenous Human Normal Immunoglobulin 10% in Adults With Chronic Immune Thrombocytopenia (ITP)
- University of Southern California, Los Angeles
Тражи се учесникФаза 3
Узраст од 18 до 70 · Оба пола · Ажурирано 22. 10. 2026. · NCT07059000RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis
- University of California Irvine, Orange
- UC Davis, Department of Neurology, Sacramento
- University of California, San Francisco, San Francisco
Тражи се учесникФаза 1/2
Узраст од 18 до 70 · Оба пола · Ажурирано 19. 10. 2026. · NCT06359041A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV)
- Stanford University, Dept. of Dermatology, Redwood City
- UC Davis, Dept. of Dermatology, Sacramento
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 15. 10. 2026. · NCT04422912RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
- University of California Irvine, Orange
- UC Davis Health, Sacramento
Тражи се учесникФаза 1/2
Узраст од 12 до 65 · Оба пола · Ажурирано 6. 10. 2026. · NCT06121297Remdesivir for the Treatment of Upper Respiratory Tract Infection Due to RSV in Immunocompromised Individuals
- City of Hope Comprehensive Cancer Center, Duarte
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 1. 10. 2026. · NCT06817889A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
- GSK Investigational Site, Los Angeles
- GSK Investigational Site, Los Angeles
- GSK Investigational Site, Orange
- и још 2
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 8. 9. 2026. · NCT06572384Study of BHV-1300 in Graves' Disease
- Site-103, South Gate
Тражи се учесникФаза 1
Узраст од 18 до 65 · Оба пола · Ажурирано 31. 7. 2026. · NCT06980649KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis
- Ronald Reagan UCLA Medical Center, Los Angeles
- University of California, Irvine, Orange
- Stanford University Medical Center, Palo Alto
Тражи се учесникФаза 2/3
Узраст од 18 до 75 · Оба пола · Ажурирано 29. 7. 2026. · NCT06193889A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- City of Hope, Duarte
- Children's Hospital of Los Angeles, Glendale
- Scripps Green Hospital, La Jolla
- и још 8
Тражи се учесникОпсервациона студија
Сви узрасти · Оба пола · Ажурирано 6. 7. 2026. · NCT01351545Study of Single Doses of SBT777101 in Subjects With Rheumatoid Arthritis
- UCSF Medical Center, San Francisco
- Stanford Medical Center, Stanford
Тражи се учесникФаза 1
Узраст од 18 до 70 · Оба пола · Ажурирано 30. 6. 2026. · NCT06201416Atacicept in Multiple Glomerular Diseases
- Vera Therapeutics, Brisbane
Тражи се учесникФаза 2
Узраст 2 и старији · Оба пола · Ажурирано 26. 6. 2026. · NCT06983028A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
- Wallace Rheumatic Center, Beverly Hills
- Providence Medical Foundation, Fullerton
- University of California Irvine, Irvine
- и још 2
Тражи се учесникФаза 1
Узраст од 12 до 70 · Оба пола · Ажурирано 22. 5. 2026. · NCT06308978A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell ( CAR-T) Therapy in Subjects With Non-relapsing and Progressive Forms of Multiple Sclerosis
- Stanford Multiple Sclerosis Center, Palo Alto
Тражи се учесникФаза 1
Узраст од 18 до 65 · Оба пола · Ажурирано 27. 2. 2026. · NCT06138132Central Vein Sign in Multiple Sclerosis Extension Study
- Cedars-Sinai Medical Center, Los Angeles
Тражи се учесник
Узраст од 18 до 65 · Оба пола · Ажурирано 20. 2. 2026. · NCT07424027Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project
- University of California, San Diego, La Jolla
Тражи се учесникОпсервациона студија
Сви узрасти · Жене · Ажурирано 28. 1. 2025. · NCT02103361Clinical Validation of the Role of microRNA Binding Site Mutations in Cancer Risk, Prevention and Treatment
- MiraKind, Los Angeles
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
Узраст 18 и старији · Оба пола · Ажурирано 23. 1. 2025. · NCT02253251Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions
- Southern California Hospital at Culver City / Southern California Hospital at Hollywood / Multiple US-based Sub-Investigator Sites, Culver City
Тражи се учесникФаза 1/2Здраве особе су добродошле
Узраст 18 и старији · Оба пола · Ажурирано 29. 4. 2022. · NCT04684602Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.